Doyle Mittie Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$411,606.58

Insider Activity of Doyle Mittie

According to the SEC Form 4 filings, Doyle Mittie, being in a position of

  1. Chief Medical Officer at Avalo Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 151516 shares for $2.98M,
    over all time since 2026-03-16, has bought 0 shares, and sold 151516 shares for $2.98M.

Biography of Doyle Mittie

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,977,83013100

Comparison of Insiders on Amount of Buys and Sells

2026-08-28SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
679
0.0016%
$20.00$13,580-23.58%
2026-08-17SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
1,000
0.0023%
$20.00$20,000-22.46%
2026-08-10SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
679
0.0016%
$20.00$13,580-19.6%
2026-07-27SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
1,000
0.0091%
$20.00$20,000-15.18%
2026-06-30SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
4,654
0.0446%
$20.00$93,080-1.62%
2026-06-23SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
1,450
0.013%
$18.00$26,100+2.08%
2026-05-28SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
679
0.006%
$16.00$10,864+6.85%
2026-05-15SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
3,000
0.0281%
$18.76$56,280-6.48%
2026-05-06SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
106,555
0.8946%
$20.68$2.2M-21.23%
2026-05-05SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
1,679
0.0146%
$16.00$26,864+6%
2026-04-06SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
3,970
0.0389%
$18.01$71,508-0.06%
2026-04-01SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
679
0.0058%
$16.00$10,864-2.57%
2026-03-16SaleAvalo Therapeutics, Inc.
AVTX
Chief Medical Officer
25,492
0.2275%
$16.15$411,607+0.69%
Total: 13
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.